APO RESEARCH · REPORT
Developmental and Reproductive Toxicology (DART) Services
Selected research
Industry Growth & Trends
Global Developmental and Reproductive Toxicology (DART) Services Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Developmental and Reproductive Toxicology (DART) Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Developmental and Reproductive Toxicology (DART) Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Developmental and Reproductive Toxicology (DART) Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Developmental and Reproductive Toxicology (DART) Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Developmental and Reproductive Toxicology (DART) Services market include AnaPath Services, Frontage, WuXi AppTec, Creative Animodel, Pharmaron, Labcorp, RCC, Creative Biolabs and IITRI, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Developmental and Reproductive Toxicology (DART) Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Developmental and Reproductive Toxicology (DART) Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Developmental and Reproductive Toxicology (DART) Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Developmental and Reproductive Toxicology (DART) Services.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Developmental and Reproductive Toxicology (DART) Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Developmental and Reproductive Toxicology (DART) Services Market by Company
AnaPath Services
Frontage
WuXi AppTec
Creative Animodel
Pharmaron
Labcorp
RCC
Creative Biolabs
IITRI
Syngene
JOINN
Inotiv
Accelera
Charles River
Developmental and Reproductive Toxicology (DART) Services Segment by Type
Fertility and Early Embryonic Development (FEED) study
Embryofetal Development (EFD) study
Pre- and Post-natal (PPND) study
Others
Developmental and Reproductive Toxicology (DART) Services Segment by Application
Biotechnology
Academic Research
Others
Developmental and Reproductive Toxicology (DART) Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Developmental and Reproductive Toxicology (DART) Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Developmental and Reproductive Toxicology (DART) Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Developmental and Reproductive Toxicology (DART) Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Developmental and Reproductive Toxicology (DART) Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Fertility and Early Embryonic Development (FEED) study
- Embryofetal Development (EFD) study
- Pre- and Post-natal (PPND) study
- Others
Applications
- Biotechnology
- Academic Research
- Others
Companies covered
- AnaPath Services
- Frontage
- WuXi AppTec
- Creative Animodel
- Pharmaron
- Labcorp
- RCC
- Creative Biolabs
- IITRI
- Syngene
- JOINN
- Inotiv
- Accelera
- Charles River
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Developmental and Reproductive Toxicology (DART) Services Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Region (2021-2032)
- 1.4.1 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Region (2021-2026)
- 1.4.2 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Region (2027-2032)
- 1.5 Key Regions Developmental and Reproductive Toxicology (DART) Services Market Size (2021-2032)
- 1.5.1 North America Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate (2021-2032)
- 1.5.4 South America Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate (2021-2032)
2 Developmental and Reproductive Toxicology (DART) Services Market by Type
- 2.1 Type Introduction
- 2.1.1 Fertility and Early Embryonic Development (FEED) study
- 2.1.2 Embryofetal Development (EFD) study
- 2.1.3 Pre- and Post-natal (PPND) study
- 2.1.4 Others
- 2.2 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Type
- 2.2.1 Global Developmental and Reproductive Toxicology (DART) Services Market Size Overview by Type (2021-2032)
- 2.2.2 Global Developmental and Reproductive Toxicology (DART) Services Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Developmental and Reproductive Toxicology (DART) Services Market Size Forecasted by Type (2027-2032)
- 2.3 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Regions
- 2.3.1 North America Developmental and Reproductive Toxicology (DART) Services Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Developmental and Reproductive Toxicology (DART) Services Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Developmental and Reproductive Toxicology (DART) Services Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Developmental and Reproductive Toxicology (DART) Services Market Size Breakdown by Type (2021-2026)
3 Developmental and Reproductive Toxicology (DART) Services Market by Application
- 3.1 Type Introduction
- 3.1.1 Biotechnology
- 3.1.2 Academic Research
- 3.1.3 Others
- 3.2 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Application
- 3.2.1 Global Developmental and Reproductive Toxicology (DART) Services Market Size Overview by Application (2021-2032)
- 3.2.2 Global Developmental and Reproductive Toxicology (DART) Services Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Developmental and Reproductive Toxicology (DART) Services Market Size Forecasted by Application (2027-2032)
- 3.3 Global Developmental and Reproductive Toxicology (DART) Services Market Size by Regions
- 3.3.1 North America Developmental and Reproductive Toxicology (DART) Services Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Developmental and Reproductive Toxicology (DART) Services Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Developmental and Reproductive Toxicology (DART) Services Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Developmental and Reproductive Toxicology (DART) Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Developmental and Reproductive Toxicology (DART) Services Industry Trends
- 4.2 Developmental and Reproductive Toxicology (DART) Services Industry Drivers
- 4.3 Developmental and Reproductive Toxicology (DART) Services Industry Opportunities and Challenges
- 4.4 Developmental and Reproductive Toxicology (DART) Services Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Developmental and Reproductive Toxicology (DART) Services Revenue (2021-2026)
- 5.2 Global Developmental and Reproductive Toxicology (DART) Services Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Developmental and Reproductive Toxicology (DART) Services Key Company Headquarters & Area Served
- 5.4 Global Developmental and Reproductive Toxicology (DART) Services Company, Product Type & Application
- 5.5 Global Developmental and Reproductive Toxicology (DART) Services Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Developmental and Reproductive Toxicology (DART) Services Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Developmental and Reproductive Toxicology (DART) Services Players Market Share by Revenue in 2025
- 5.6.3 2025 Developmental and Reproductive Toxicology (DART) Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 AnaPath Services
- 6.1.1 AnaPath Services Company Information
- 6.1.2 AnaPath Services Business Overview
- 6.1.3 AnaPath Services Developmental and Reproductive Toxicology (DART) Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 AnaPath Services Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 6.1.5 AnaPath Services Recent Developments
- 6.2 Frontage
- 6.2.1 Frontage Company Information
- 6.2.2 Frontage Business Overview
- 6.2.3 Frontage Developmental and Reproductive Toxicology (DART) Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Frontage Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 6.2.5 Frontage Recent Developments
- 6.3 WuXi AppTec
- 6.3.1 WuXi AppTec Company Information
- 6.3.2 WuXi AppTec Business Overview
- 6.3.3 WuXi AppTec Developmental and Reproductive Toxicology (DART) Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 WuXi AppTec Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 6.3.5 WuXi AppTec Recent Developments
- 6.4 Creative Animodel
- 6.4.1 Creative Animodel Company Information
- 6.4.2 Creative Animodel Business Overview
- 6.4.3 Creative Animodel Developmental and Reproductive Toxicology (DART) Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Creative Animodel Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 6.4.5 Creative Animodel Recent Developments
- 6.5 Pharmaron
- 6.5.1 Pharmaron Company Information
- 6.5.2 Pharmaron Business Overview
- 6.5.3 Pharmaron Developmental and Reproductive Toxicology (DART) Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Pharmaron Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 6.5.5 Pharmaron Recent Developments
- 6.6 Labcorp
- 6.6.1 Labcorp Company Information
- 6.6.2 Labcorp Business Overview
- 6.6.3 Labcorp Developmental and Reproductive Toxicology (DART) Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Labcorp Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 6.6.5 Labcorp Recent Developments
- 6.7 RCC
- 6.7.1 RCC Company Information
- 6.7.2 RCC Business Overview
- 6.7.3 RCC Developmental and Reproductive Toxicology (DART) Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 RCC Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 6.7.5 RCC Recent Developments
- 6.8 Creative Biolabs
- 6.8.1 Creative Biolabs Company Information
- 6.8.2 Creative Biolabs Business Overview
- 6.8.3 Creative Biolabs Developmental and Reproductive Toxicology (DART) Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Creative Biolabs Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 6.8.5 Creative Biolabs Recent Developments
- 6.9 IITRI
- 6.9.1 IITRI Company Information
- 6.9.2 IITRI Business Overview
- 6.9.3 IITRI Developmental and Reproductive Toxicology (DART) Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 IITRI Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 6.9.5 IITRI Recent Developments
- 6.10 Syngene
- 6.10.1 Syngene Company Information
- 6.10.2 Syngene Business Overview
- 6.10.3 Syngene Developmental and Reproductive Toxicology (DART) Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Syngene Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 6.10.5 Syngene Recent Developments
- 6.11 JOINN
- 6.11.1 JOINN Company Information
- 6.11.2 JOINN Business Overview
- 6.11.3 JOINN Developmental and Reproductive Toxicology (DART) Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 JOINN Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 6.11.5 JOINN Recent Developments
- 6.12 Inotiv
- 6.12.1 Inotiv Company Information
- 6.12.2 Inotiv Business Overview
- 6.12.3 Inotiv Developmental and Reproductive Toxicology (DART) Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Inotiv Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 6.12.5 Inotiv Recent Developments
- 6.13 Accelera
- 6.13.1 Accelera Company Information
- 6.13.2 Accelera Business Overview
- 6.13.3 Accelera Developmental and Reproductive Toxicology (DART) Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Accelera Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 6.13.5 Accelera Recent Developments
- 6.14 Charles River
- 6.14.1 Charles River Company Information
- 6.14.2 Charles River Business Overview
- 6.14.3 Charles River Developmental and Reproductive Toxicology (DART) Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Charles River Developmental and Reproductive Toxicology (DART) Services Product Portfolio
- 6.14.5 Charles River Recent Developments
7 North America
- 7.1 North America Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021-2026)
- 7.3 North America Developmental and Reproductive Toxicology (DART) Services Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021-2026)
- 8.3 Europe Developmental and Reproductive Toxicology (DART) Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Developmental and Reproductive Toxicology (DART) Services Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021-2026)
- 10.3 South America Developmental and Reproductive Toxicology (DART) Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Developmental and Reproductive Toxicology (DART) Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst